[Translation] A multicenter, randomized, double-blind, active-controlled phase III clinical study to evaluate the effectiveness and safety of therapeutic Bacillus Calmette-Guérin (BCG) in preventing postoperative recurrence of intermediate- and high-risk non-muscle-invasive bladder cancer.
主要目的:评估治疗用BCG用于中、高危非肌层浸润性膀胱癌患者TURBt术后辅助治疗的疗效。
次要目的:评估治疗用BCG用于中、高危非肌层浸润性膀胱癌患者TURBt术后辅助治疗的安全性和耐受性。
[Translation] Main purpose: To evaluate the efficacy of therapeutic BCG as adjuvant therapy for patients with intermediate- and high-risk non-muscle-invasive bladder cancer after TURBt surgery.
Secondary purpose: To evaluate the safety and tolerability of therapeutic BCG for adjuvant therapy after TURBt in patients with intermediate- and high-risk non-muscle-invasive bladder cancer.